Companies we are currently assisting
.png/:/rs=w:600,cg:true,m)
Fundraising - Funding Secured through DON
Our team of experienced Business Development experts are assisting the CEO of NUAgo Therapeutics with an undisclosed funding round.
NUAgo Therapeutics is redefining the precision approach in cancer therapeutics. We are a pre-clinical stage company developing single-construct short RNAs that target dozens of critical cancer essential genes in systemic delivery platform that kill tumors specifically without observed toxicity in normal tissues.
Fundraising - Funding Secured through DON
Our team of experienced Business Development experts are assisting the CEO of Pristine Surgical with an undisclosed funding round.
DermaSensor is more than technology; it is a commitment to helping physicians detect skin cancer at the point of care with the first AI-powered medical device for all three common skin cancers.
Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.
Fundraising
Our team of experienced Business Development experts are assisting the CEO of Arcoris Bio with an undisclosed funding round.
Arcoris bio's mission is to empower personalized medicine with multiplex biomarker technologies.
Fundraising and strategic partnerships
Amyl Therapeutics is a preclinical-stage biotechnology company developing Pan-Amyloid Immunotherapy, a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases.
Fundraising and strategic partnerships
UNION therapeutics is a privately held, clinical stage, pharmaceutical development company advancing novel treatment options within immunology, a large and fast-growing therapeutic area. UNION is headquartered in Hellerup, Denmark, and led by an international team combining biotech entrepreneurs and seasoned pharma executives, with a track record of developing and launching more than fifteen marketed drugs.
Fundraising and strategic partnerships
Consano Biologics is a biotechnology company focused on developing innovative biologic therapeutics for orthopedic conditions. Their lead product, C-1101, is an Allogenic Multi-Protein Therapeutic (AMPT) aimed at treating painful conditions such as chronic Lumbosacral Radiculopathy.
Fundraising and strategic partnerships
HarleyDoc provides a private healthcare service for those who want the best treatments from carefully-vetted, highly qualified and experienced medical professionals.